2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]methyl}acetamide
Chemical Structure Depiction of
2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]methyl}acetamide
2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]methyl}acetamide
Compound characteristics
| Compound ID: | Y043-5013 |
| Compound Name: | 2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]methyl}acetamide |
| Molecular Weight: | 392.37 |
| Molecular Formula: | C19 H16 N6 O4 |
| Smiles: | C(C1C(Nc2ccccc2C(N1)=O)=O)C(NCc1nc(c2ccncc2)no1)=O |
| Stereo: | RACEMIC MIXTURE |
| logP: | 0.9052 |
| logD: | 0.8927 |
| logSw: | -1.736 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 3 |
| Polar surface area: | 116.193 |
| InChI Key: | AZNNQYLQYUOCIS-AWEZNQCLSA-N |